Inhibition of eosinophil activation mediated by a toll-like receptor 7 ligand with a combination of procaterol and budesonide

International Archives of Allergy and Immunology

Volumn 155, Issue SUPPL. 1, 2011, Pages 85-89

  Hiraguchi, Yukiko ^a,b   Tanida, Hisashi ^a   Hosoki, Koa ^a   Nagao, Mizuho ^a   Tokuda, Reiko ^a   Fujisawa, Takao ^a  

^a MIE NATIONAL HOSPITAL   (Japan)

^b SAISEIKAI NAKATSU HOSPITAL   (Japan)

Author keywords

Asthma; Budesonide; Combination therapy; Eosinophil; Inhaled corticosteroid; Procaterol; R 837; Short acting 2 agonist; Toll like receptor 7; Virus infection

Indexed keywords

BUDESONIDE; CD11B ANTIGEN; CYTOCHROME C; IMIQUIMOD; INTERLEUKIN 8; OXYGEN; PROCATEROL; SUPEROXIDE; TOLL LIKE RECEPTOR 7;

ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; NORMAL HUMAN; PRIORITY JOURNAL;

AMINOQUINOLINES; ANTIGENS, CD11B; ANTIVIRAL AGENTS; BUDESONIDE; DRUG COMBINATIONS; EOSINOPHILS; HUMANS; INTERLEUKIN-8; PROCATEROL; SUPEROXIDES; TOLL-LIKE RECEPTOR 7;

EID: 79958084426     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000327438     Document Type: Conference Paper

References (33)

1. Jackson DJ, Johnston SL: The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol 2010;125:1178-1187, quiz 1188-1179.
2. Guilbert TW, Denlinger LC: Role of infection in the development and exacerbation of asthma. Expert Rev Respir Med 2010;4:71-83.
3. Harrison AM, Bonville CA, Rosenberg HF, Domachowske JB: Respiratory syncytial virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. Am J Respir Crit Care Med 1999;159:1918-1924. (Pubitemid 29275064)
4. Everard ML, Swarbrick A, Wrightham M, McIntyre J, Dunkley C, James PD, Sewell HF, Milner AD: Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child 1994;71:428-432. (Pubitemid 24349852)
5. Garofalo R, Kimpen JL, Welliver RC, Ogra PL: Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr 1992; 120:28-32.
6. Matthews SP, Tregoning JS, Coyle AJ, Hussell T, Openshaw PJ: Role of ccl11 in eosinophilic lung disease during respiratory syncytial virus infection. J Virol 2005;79:2050-2057. (Pubitemid 40204562)
7. Johnson TR, Parker RA, Johnson JE, Graham BS: Il-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge. J Immunol 2003;170:2037-2045. (Pubitemid 36197425)
8. Phipps S, Lam CE, Mahalingam S, Newhouse M, Ramirez R, Rosenberg HF, Foster PS, Matthaei KI: Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood 2007;110:1578-1586. (Pubitemid 47443974)
9. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, Iwasaki A, Flavell RA: Recognition of single-stranded RNA viruses by toll-like receptor 7. Proc Natl Acad Sci USA 2004;101:5598-5603. (Pubitemid 38481202)
10. Nagase H, Okugawa S, Ota Y, Yamaguchi M, Tomizawa H, Matsushima K, Ohta K, Yamamoto K, Hirai K: Expression and function of toll-like receptors in eosinophils: activation by toll-like receptor 7 ligand. J Immunol 2003;171:3977-3982. (Pubitemid 37238671)
11. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A: Effect of inhaled formoterol and budesonide on exacerbations of asthma - Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405-1411.
12. Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T: Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2000; 105:1108-1116. (Pubitemid 30418788)
13. Fujisawa T, Kato Y, Terada A, Iguchi K, Kamiya H: Synergistic effect of theophylline and procaterol on interleukin-5-induced degranulation from human eosinophils. J Asthma 2002;39:21-27. (Pubitemid 34188732)
14. Yoshimura T, Kurita C, Nagao T, Usami E, Nakao T, Watanabe S, Kobayashi J, Yamazaki F, Tanaka H, Inagaki N, Nagai H: Inhibition of tumor necrosis factor-alpha and interleukin-1-beta production by beta-adrenoceptor agonists from lipopoly saccharide-stimulated human peripheral blood mononuclear cells. Pharmacology 1997;54: 144-152. (Pubitemid 27136077)
15. Mirza ZN, Tokuyama K, Arakawa H, Kato M, Mochizuki H, Morikawa A: Inhaled procaterol inhibits histamine-induced airflow obstruction and microvascular leakage in guinea-pig airways with allergic inflammation. Clin Exp Allergy 1998;28:644-652. (Pubitemid 28238280)
16. Tashimo H, Yamashita N, Ishida H, Nagase H, Adachi T, Nakano J, Yamamura K, Yano T, Yoshihara H, Ohta K: Effect of procaterol, a beta(2) selective adrenergic receptor agonist, on airway inflammation and hyperresponsiveness. Allergol Int 2007;56: 241-247.
17. Yoshida N, Muraguchi M, Kamata M, Ikezono K, Mori T: Procaterol potentiates the anti-inflammatory activity of budesonide on eosinophil adhesion to lung fibroblasts. Int Arch Allergy Immunol 2009;150:352-358.
18. Fujisawa T, Kato Y, Nagase H, Atsuta J, Terada A, Iguchi K, Kamiya H, Morita Y, Kitaura M, Kawasaki H, Yoshie O, Hirai K: Chemokines induce eosinophil degranulation through CCR-3. J Allergy Clin Immunol 2000;106:507-513. (Pubitemid 32037703)
19. Hiraguchi Y, Nagao M, Hosoki K, Tokuda R, Fujisawa T: Neutrophil proteases activate eosinophil function in vitro. Int Arch Allergy Immunol 2008;146(suppl 1):16-21.
20. Mansson A, Cardell LO: Role of atopic status in Toll-like receptor (TLR)7- and TLR9-mediated activation of human eosinophils. J Leukoc Biol 2009;85:719-727.
21. Wong CK, Cheung PF, Ip WK, Lam CW: Intracellular signaling mechanisms regulating Toll-like receptor-mediated activation of eosinophils. Am J Respir Cell Mol Biol 2007;37: 85-96. (Pubitemid 46999540)
22. Okubo Y, Hossain M, Horie S, Momose T, Suzuki J, Isobe M, Sekiguchi M: Inhibitory effects of theophylline and procaterol on eosinophil function. Intern Med 1997;36:276-282. (Pubitemid 27286416)
23. Tachibana A, Kato M, Kimura H, Fujiu T, Suzuki M, Morikawa A: Inhibition by fenoterol of human eosinophil functions including beta2-adrenoceptor- independent actions. Clin Exp Immunol 2002;130:415-423. (Pubitemid 35418324)
24. Yasui K, Kobayashi N, Yamazaki T, Agematsu K, Matsuzaki S, Nakata S, Baba A: Differential effects of short-acting beta2-agonists on human granulocyte functions. Int Arch Allergy Immunol 2006;139:1-8. (Pubitemid 43048599)
25. Ueki S, Usami A, Oyamada H, Saito N, Chiba T, Mahemuti G, Ito W, Kato H, Kayaba H, Chihara J: Procaterol upregulates peroxisome proliferator-activated receptor-gamma expression in human eosinophils. Int Arch Allergy Immunol 2006;140(suppl 1):35-41. (Pubitemid 43882383)
26. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ: Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143-178.
27. Aksoy MO, Mardini IA, Yang Y, Bin W, Zhou S, Kelsen SG: Glucocorticoid effects on the beta-adrenergic receptor-adenylyl cyclase system of human airway epithelium. J Allergy Clin Immunol 2002;109:491-497. (Pubitemid 34234201)
28. Usmani OS, Ito K, Maneechotesuwan K, Ito M, Johnson M, Barnes PJ, Adcock IM: Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. Am J Respir Crit Care Med 2005;172: 704-712. (Pubitemid 41324225)
29. Kaur M, Chivers JE, Giembycz MA, Newton R: Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells. Mol Pharmacol 2008;73:203-214. (Pubitemid 350294211)
30. Edwards MR, Johnson MW, Johnston SL: Combination therapy: synergistic suppression of virus-induced chemokines in airway epithelial cells. Am J Respir Cell Mol Biol 2006;34:616-624.
31. Liu YJ: Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 2006;203:269-273.
32. Harada M, Hirota T, Jodo AI, Hitomi Y, Sakashita M, Tsunoda T, Miyagawa T, Doi S, Kameda M, Fujita K, Miyatake A, Enomoto T, Noguchi E, Masuko H, Sakamoto T, Hizawa N, Suzuki Y, Yoshihara S, Adachi M, Ebisawa M, Saito H, Matsumoto K, Nakajima T, Mathias RA, Rafaels N, Barnes KC, Himes BE, Duan QL, Tantisira KG, Weiss ST, Nakamura Y, Ziegler SF, Tamari M: TSLP promoter polymorphisms are associated with susceptibility to bronchial asthma. Am J Respir Cell Mol Biol 2010, E-pub ahead of print.
33. Prazma CM, Kral KM, Gul N, Yancey SW, Stempel DA: Controller medications and their effects on asthma exacerbations temporally associated with upper respiratory infections. Respir Med 2010;104:780-787.